With a truly patient-focussed approach we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Sourcing commercial drug products for clinical trials can be a complex process and is often one of the last considerations during study design. Our experienced Global Sourcing Team is uniquely positioned to support you through the commercial drug sourcing process with their deep understanding of clinical trials and commercial drug markets.
Our Medical Affairs team comprises of highly experienced medical, pharmacovigilance, patient access, patient advocacy and centricity, and bioethics professionals who work across all our early access programs, embedding a patient centred approach within our operational processes.
We have an experienced team of Physicians and Medical Writers who are dedicated to supporting Early Access Programs and Real-World Data.
Our services include:
‘Our highly experienced team work across all our early access programs, embedding a patient centered approach within our operational processes.’
Our dedicated Patient Advocacy and Patient Centricity teams have vast experience in designing and delivering patient centric early access programs. They support throughout the delivery of all our programs to ensure the design is customized to the nuances of the condition and the needs of the community, looking to minimize patient, family and caregiver burden and co-create with patient communities whenever possible.
Bionical Emas have long standing partnerships with independent bioethicists who have extensive global experience in access to investigational medical products, providing direct guidance to help craft ethical and equitable programs that meet the diverse needs of our clients and provide additional expertise/advise when required.
Requirement for a global EAP of a rare disease on behalf of a US biotech partner.
Rescue of a global oncology EAP on behalf of a large pharmaceutical company.
Working with a top 20 pharmaceutical company to guide the evolution of their public policy for providing pre-approval access to gene therapy.
Discover more about the services and capabilities Bionical Emas has to offer
